Implaser Innovative Technologiessp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2003-12-01
Share capital
51,975.00 PLN
Registered address
Fiszera 14, 80-231 Gdańsk, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 65 days early.
- 202504/06/2026
- 202418/05/2025
- 202323/06/2024
- 202231/03/2023
- 202101/06/2022
- 202018/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering999 / 1,565
Top 64%
Results vs industry
Revenue
This companyUSD 27.92kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 155.34MedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 27.68kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 11.24kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Bartosz Stanisław Pietrzykowski – President
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Zbigniew Cenianage 71 | 80 | $5,942.73 | 42.328% |
Bartosz Stanisław Pietrzykowskiage 49 | 77 | $5,719.88 | 40.7407% |
Others | 32 | $2,377.09 | 16.9313% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1995-01-01.
04 1160 2202 0000 0000 5069 7879
48 1540 1098 2059 0000 4157 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $177,433.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 23, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $55,518$55,518 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 19, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $46$46 | POLITECHNIKA GDAŃSKA | |
| Dec 27, 2017 | Aid for research and development projects: industrial research | $121.8K$121,769 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eurxsp. z o.o. | $1,644,555.44 | eurx.com.pl | ||
| Medsource Polskasp. z o.o. | $1,620,329.12 | medsource.com.pl | ||
| Wasatsp. z o.o. | $989,794.30 | wasat.pl | ||
| Indoornavisp. z o.o. | $932,972.68 | indoornavi.me | ||
| TCIsp. z o.o. | $143,197.19 | tci.pl | ||
| Centrum Badawczo Rozwojowe Future Solutionssp. z o.o. | $63,890.38 | cbrfs.com | ||
| Basic Solutionsp. z o.o. | $31,812.74 | basicsolution.eu | ||
| Bałtycka Agencja Poszanowania Energiisp. z o.o. | $28,346.34 | bape.com.pl | ||
| Flying Gprsp. z o.o. | $4,783.58 | flyinggpr.pl | ||
| Mhb-Rdsp. z o.o. | $2,498.80 | mhb-rd.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-12-08 | PKD change (Removed: 17 codes; Added: 10 codes) | |
| 2013-02-19 | Name change (Implaser Centrum Technologii Laserowych → Implaser Innovative Technologies) | |
| 2013-02-19 | PKD change (Removed: 4 codes; Added: 10 codes) | |
| 2006-01-09 | Share capital increase (25,600.00 PLN → 51,975.00 PLN) | |
| 2003-12-01 | Entered in the register |
FAQ
The main business activity of Implaser Innovative Technologies focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on December 1, 2003.
The headquarters is located at: Fiszera 14, 80-231 Gdańsk.
The share capital of the company is PLN 51,975 (approx. $14,040).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $27,922 in 2025, which is an increase of 18.3% compared to 2024.
Yes, the company recorded a net profit of $155 in 2025.
The largest operating cost category falls under employee remuneration. This category amounted to $20,365 in 2025, representing 74% of all operating expenses.
Last updated: 2026-06-04